Drugs / ASCT01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01867190 | May 2013 → Mar 2016 | limb ischemia | Lifecells, LLC. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASCT01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01867190 ↗ |
| Known as | Autologous Stem Cell Transplantation | “ASCT01 (Autologous Stem Cell Transplantation)” NCT01867190 ↗ |
| Modality | Cell therapy | “autologous, bone marrow-derived stem cell preparation (ASCT01)” NCT01867190 ↗ |
| Route | Other | “via the intra- via intra-arterial infusion route” NCT01867190 ↗ |